A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer

Clinical trial NCT00982631 · UNKNOWN

Trial details

NCT number: NCT00982631
Sponsor: Radboud University Medical Center
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced/Recurrent Breast Cancer Endometrial Cancer Ovarian Cancer

Start date: 2009-06-01
Primary completion: 2012-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.